Evidence map›Paper›PMID 31291039›Full record

ArticleHuman brain mapping2019

Dopaminergic modulation of motor network compensatory mechanisms in Parkinson's disease.

Maya A Jastrzębowska, Renaud Marquis, Lester Melie-García, Antoine Lutti, Ferath Kherif, Michael H Herzog, Bogdan Draganski

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Human brain mapping, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05637593 (Effects of Training Involving Rhythmic Auditory Stimulation on Upper-limb Movements in Patients With Parkinson's Disease), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05637593 nacompletednot on this mapstarted 2023, after this paper: background citation

Effects of Training Involving Rhythmic Auditory Stimulation on Upper-limb Movements in Patients With Parkinson's Disease

TypeinterventionalSponsorThe Hong Kong Polytechnic UniversityRan2023 to 2025Enrolled38ConditionsAcoustic Stimulation, Parkinson Disease, Movement, Abnormal, BradykinesiaArmsUpper-limb movement training with the aid of RAS, Upper-limb movement training without the aid of RAS
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Maya A JastrzębowskaLaboratory of Psychophysics, Brain Mind Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.ORCID 0000-0002-2273-2881
Renaud MarquisLaboratory for Research in Neuroimaging (LREN), Department of Clinical Neuroscience, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Lester Melie-GarcíaLaboratory for Research in Neuroimaging (LREN), Department of Clinical Neuroscience, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID 0000-0001-5602-8916
Antoine LuttiLaboratory for Research in Neuroimaging (LREN), Department of Clinical Neuroscience, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Ferath KherifLaboratory for Research in Neuroimaging (LREN), Department of Clinical Neuroscience, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Michael H HerzogLaboratory of Psychophysics, Brain Mind Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Bogdan DraganskiLaboratory for Research in Neuroimaging (LREN), Department of Clinical Neuroscience, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
University of Lausanne · CHÉcole Polytechnique Fédérale de Lausanne · CHMax Planck Institute for Human Cognitive and Brain Sciences · DEUniversity Hospital of Geneva · CH

Funding

Fondation LeenaardsFondation ROGER DE SPOELBERCHH2020 Future and Emerging Technologies 720270Partridge FoundationSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 32003B_135679Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 32003B_159780Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung NCCR-Synapsy 125759Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung NCCR-Synapsy 565593
6 · The paper itself

Abstract

The dopaminergic system has a unique gating function in the initiation and execution of movements. When the interhemispheric imbalance of dopamine inherent to the healthy brain is disrupted, as in Parkinson's disease (PD), compensatory mechanisms act to stave off behavioral changes. It has been proposed that two such compensatory mechanisms may be (a) a decrease in motor lateralization, observed in drug-naïve PD patients and (b) reduced inhibition - increased facilitation. Seeking to investigate the differential effect of dopamine depletion and subsequent substitution on compensatory mechanisms in non-drug-naïve PD, we studied 10 PD patients and 16 healthy controls, with patients undergoing two test sessions - "ON" and "OFF" medication. Using a simple visually-cued motor response task and fMRI, we investigated cortical motor activation - in terms of laterality, contra- and ipsilateral percent BOLD signal change and effective connectivity in the parametric empirical Bayes framework. We found that decreased motor lateralization persists in non-drug-naïve PD and is concurrent with decreased contralateral activation in the cortical motor network. Normal lateralization is not reinstated by dopamine substitution. In terms of effective connectivity, disease-related changes primarily affect ipsilaterally-lateralized homotopic cortical motor connections, while medication-related changes affect contralaterally-lateralized homotopic connections. Our findings suggest that, in non-drug-naïve PD, decreased lateralization is no longer an adaptive cortical mechanism, but rather the result of maladaptive changes, related to disease progression and long-term dopamine replacement. These findings highlight the need for the development of noninvasive therapies, which would promote the adaptive mechanisms of the PD brain.

Indexed as

Adaptation, PhysiologicalAgedBayes TheoremCase-Control StudiesConnectomeDominance, CerebralDopamineDopamine AgonistsFemaleFootHandHumansMagnetic Resonance ImagingMaleMiddle AgedModels, NeurologicalDopamineDopamine Agonistsdynamic causal modelingeffective connectivityfMRIlateralizationparametric empirical BayesParkinson's disease

Identifiers

PMID31291039
PMCPMC6865418
OpenAlexW2957823613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.